Maze Therapeutics (MAZE) experienced a significant intraday surge of 5.17% during Thursday's trading session, indicating strong investor interest.
The upward movement is attributed to recent analyst insights on the company, as coverage from financial analysts has brought attention to Maze Therapeutics, potentially influencing market sentiment and trading activity.